Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
Titel:
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
Auteur:
Zhou, Nanruoyi Velez, Maria A Bachrach, Benjamin Gukasyan, Jaklin Fares, Charlene M. Cummings, Amy L. Lind-Lebuffe, Jackson P. Akingbemi, Wisdom O. Li, Debory Y. Brodrick, Paige M. Yessuf, Nawal M. Rettinger, Sarah Grogan, Tristan Rochigneux, Philippe Goldman, Jonathan W. Garon, Edward B. Lisberg, Aaron